Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Profusa, Inc. (PFSA)

0.7511 -0.0198 (-2.57%)
As of 12:50:41 PM EDT. Market Open.
Chart Range Bar
Loading chart for PFSA
  • Previous Close 0.7709
  • Open 0.7750
  • Bid 1.1000 x 400
  • Ask 0.7520 x 200
  • Day's Range 0.7301 - 0.7750
  • 52 Week Range 0.7000 - 1,965.0000
  • Volume 86,178
  • Avg. Volume 3,518,832
  • Market Cap (intraday) 454,901
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 897.2600
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

profusa.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PFSA
99.90%
S&P 500 (^GSPC)
10.77%

1-Year Return

PFSA
99.96%
S&P 500 (^GSPC)
11.14%

3-Year Return

PFSA
100.00%
S&P 500 (^GSPC)
81.97%

5-Year Return

PFSA
100.00%
S&P 500 (^GSPC)
64.64%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -725.26%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -42.97M

  • Diluted EPS (ttm)

    897.2600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    719k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -19.13M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: